Related Experiment Video
Updated: Apr 14, 2026

In vivo Imaging Method to Distinguish Acute and Chronic Inflammation
Published on: August 16, 2013
NADPH oxidases and inflammatory bowel disease
Giang Lam, Vasso Apostolopoulos, Anthony Zulli
1Enteric Neuropathy Lab, College of Health and Biomedicine, Victoria University, Melbourne, Australia. Kulmira.Nurgali@vu.edu.au.
Nicotinamide adenine dinucleotide phosphate oxidase (NADPH oxidase, NOX) enzymes produce reactive oxygen species (ROS). Upregulated NOX contributes to inflammatory bowel disease (IBD) pathogenesis, suggesting NOX inhibition as a potential therapeutic strategy.
Area of Science:
- Biochemistry
- Cell Biology
- Gastroenterology
Background:
- Nicotinamide adenine dinucleotide phosphate oxidase (NADPH oxidase, NOX) enzymes generate reactive oxygen species (ROS).
- Excessive ROS production leads to oxidative stress, implicated in various pathologies.
- Oxidative stress is a key factor in inflammatory bowel disease (IBD) development and progression.
Purpose of the Study:
- To explore the role of NOX enzymes in IBD pathogenesis.
- To investigate NOX gene variants' impact on IBD susceptibility.
- To evaluate pharmacological NOX inhibition as a potential IBD therapeutic strategy.
Main Methods:
- Review of existing literature on NOX enzymes and IBD.
- Analysis of correlations between NOX expression and gastrointestinal inflammation.
- Examination of studies on NOX gene variants and IBD susceptibility.
Main Results:
- A positive correlation exists between upregulated NOX and gastrointestinal inflammation.
- Specific NOX gene variants influence an individual's susceptibility to IBD.
- Current IBD treatments have limitations, highlighting the need for novel approaches.
Conclusions:
- NOX enzymes are significantly involved in IBD pathogenesis.
- Targeting NOX enzymes pharmacologically presents a promising, unexplored therapeutic avenue for IBD.
- Further research into NOX inhibition could lead to more effective IBD treatments.
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation

